Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

M Inada, Y Nishimura, S Ishikura, K Ishikawa… - Radiation …, 2022 - Springer
Background JCOG1015A1 is an ancillary research study to determine the organ-specific
dose constraints in head and neck carcinoma treated with intensity-modulated radiation …

[HTML][HTML] A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients

JJ Yao, FP Chen, GQ Zhou, WJ Zhang, L Xu, XJ Wang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
This study is to investigate the dose distribution of organs at risk (OARs) in cases of
nasopharyngeal carcinoma (NPC). From July 2013 to October 2014, a prospective cohort …

[HTML][HTML] Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment

L Van den Bosch, A van der Schaaf… - Radiotherapy and …, 2021 - Elsevier
Background and purpose A comprehensive individual toxicity risk profile is needed to
improve radiation treatment optimisation, minimising toxicity burden, in head and neck …

Impact of geometric uncertainties on dose distribution during intensity modulated radiotherapy of head-and-neck cancer: the need for a planning target volume and a …

O Ballivy, W Parker, T Vuong, G Shenouda… - Current …, 2006 - mdpi.com
We assessed the effect of geometric uncertainties on target coverage and on dose to the
organs at risk (OARS) during intensity-modulated radiotherapy (IMRT) for head-and-neck …

Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT

HF Lee, JH Lan, PJ Chao, HM Ting… - Cancer management …, 2018 - Taylor & Francis
Background Patients treated with radiotherapy are at risk of developing a second cancer
during their lifetime, which can directly impact treatment decision-making and patient …

A Nomogram to predict parotid gland overdose in head and neck IMRT

J Castelli, A Simon, B Rigaud, C Lafond, E Chajon… - Radiation …, 2016 - Springer
Purposes To generate a nomogram to predict parotid gland (PG) overdose and to quantify
the dosimetric benefit of weekly replanning based on its findings, in the context of intensity …

Revisiting the dose constraints for head and neck OARs in the current era of IMRT

NP Brodin, WA Tomé - Oral oncology, 2018 - Elsevier
Head and neck cancer poses a particular challenge in radiation therapy, whilst being an
effective treatment modality it requires very high doses of radiation to provide effective …

Predictive models to determine clinically relevant deviations in delivered dose for head and neck cancer

MM McCulloch, C Lee, BS Rosen, JD Kamp… - Practical radiation …, 2019 - Elsevier
Purpose This study aimed to improve the understanding of deviations between planned and
accumulated doses and to establish metrics to predict clinically significant dosimetric …

Constraints to organs at risk for treatment of head and neck cancers by intensity modulated radiation therapy

P Maingon, V Mammar, K Peignaux… - … : Journal de la Societe …, 2004 - europepmc.org
Constraint definitions in intensity modulated radiation therapy is a key point factor during the
treatment planning process. In literature some data are available about dose constraints and …

Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines

MTG Urbano, CH Clark, C Kong, E Miles… - Clinical oncology, 2007 - Elsevier
AIMS: There is considerable controversy surrounding target volume definition for parotid-
sparing intensity modulated radiotherapy (IMRT) for head and neck cancer. The aim of this …